Endocrinology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Endocrinology Tests Pipeline Market Report Overview

Endocrinology tests are the reagents used to quantify and detect endocrine hormones secreted in the human body.

The endocrinology tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segment ·       Growth Hormone (GH) Function Tests

·       Individual and Specified Hormones

·       25-OH Vitamin D Tests

·       Bone Metabolism Assays

·       Calcitonin Tests

Key Territories ·       The United States

·       Europe

·       China

·       Australia

·       South Korea

Key Regulatory Paths ·       510(k)

·       CE-IVD

·       NMPA

·       TGA

·       MDITAC

Leading Companies ·       Aeterna Zentaris Inc

·       Albert Einstein College of Medicine

·       AMS Diagnostics LLC

·       Axis-Shield Diagnostics Ltd

·       Carolina Liquid Chemistries Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

 Buy the Full Report for More Insights into the Endocrinology Tests Pipeline Market

Download a Free Report Sample

Endocrinology Tests Pipeline Market Segments

The key segments of the endocrinology tests pipeline market are Growth Hormone (GH) Function Tests, Individual and Specified Hormones, 25-OH Vitamin D Tests, Bone Metabolism Assays, and Calcitonin Tests. As of July 2024, the GH Function Tests segment accounted for the highest number of pipeline products.

Endocrinology Tests Pipeline Market Analysis by Segments, 2024 (%)

Endocrinology Tests Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Endocrinology Tests Pipeline Market

Download a Free Report Sample

Endocrinology Tests Pipeline Market Segmentation by Territories

The United States, Europe, China, Australia, and South Korea among others are a few of the key territories of the endocrinology tests pipeline market. As of July 2024, the United States accounted for the highest number of pipeline products.

Endocrinology Tests Pipeline Market Analysis by Territories, 2024 (%)

Endocrinology Tests Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Endocrinology Tests Pipeline Market

Download a Free Report Sample

Endocrinology Tests Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the endocrinology tests pipeline products market are 510(k), CE-IVD, NMPA, TGA, and MDITAC among others. As of July 2024, 510(k) was the most followed pathway for pipeline products in the endocrinology tests market.

Endocrinology Tests Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Endocrinology Tests Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Endocrinology Tests Pipeline Market

Download a Free Report Sample

Endocrinology Tests Pipeline Market – Competitive Landscape

A few of the key companies associated with the endocrinology tests pipeline market are Aeterna Zentaris Inc, Albert Einstein College of Medicine, AMS Diagnostics LLC, Axis-Shield Diagnostics Ltd, and Carolina Liquid Chemistries Corp among others.

Aeterna Zentaris Inc: Aeterna Zentaris is headquartered in Summerville, South Carolina, the US. The company’s lead product, Macrilen (macimorelin), a ghrelin receptor agonist and the orally active small molecule is used for the treatment of patients with adult growth hormone deficiency (AGHD).

Endocrinology Tests Pipeline Market Analysis by Companies, 2024
Endocrinology Tests Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Endocrinology Tests Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Endocrinology Tests Pipeline Market Segments Outlook (2024)

  • Growth Hormone (GH) Function Tests
  • Individual and Specified Hormones
  • 25-OH Vitamin D Tests
  • Bone Metabolism Assays
  • Calcitonin Tests

Endocrinology Tests Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • China
  • Australia
  • South Korea

Endocrinology Tests Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • NMPA
  • TGA
  • MDITAC

Scope

This report provides:

  • Extensive coverage of the endocrinology tests under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of endocrinology tests and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of endocrinology tests under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aeterna Zentaris Inc
Albert Einstein College of Medicine
AMS Diagnostics LLC
Axis-Shield Diagnostics Ltd
Carolina Liquid Chemistries Corp
Ceres Nanosciences Inc
Columbia University
Denka Seiken Co Ltd
DIANA Biotechnologies SRO
DiaSorin SpA
EDP Biotech Corporation
G Medical Health and Wellness
Guangzhou Wondfo Biotech Co Ltd
Hansjorg Wyss Institute for Biologically Inspired Engineering
Intelligent Bio Solutions Inc
Laboratoire HRA Pharma SAS
Manchester University NHS Foundation Trust
MyHealthTest Pty Ltd
Pearsanta Inc
Philmedi Co Ltd
Revvity Inc
Roche Diagnostics Corp
Roche Diagnostics International Ltd
Sendera Discovery
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Siemens Healthcare Diagnostics Inc
Solvd Health
Thermo Fisher Scientific Inc
Tosoh Bioscience Inc
University of California San Francisco

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 9

2 Introduction 10

2.1 Endocrinology Tests Overview 10

3 Products under Development 11

3.1 Endocrinology Tests – Pipeline Products by Stage of Development 11

3.2 Endocrinology Tests – Pipeline Products by Segment 12

3.3 Endocrinology Tests – Pipeline Products by Territory 13

3.4 Endocrinology Tests – Pipeline Products by Regulatory Path 14

3.5 Endocrinology Tests – Pipeline Products by Estimated Approval Date 15

4 Endocrinology Tests – Pipeline Products under Development by Companies 16

4.1 Endocrinology Tests Companies – Pipeline Products by Stage of Development 16

4.2 Endocrinology Tests – Pipeline Products by Stage of Development 18

5 Endocrinology Tests Companies and Product Overview 21

5.1 Aeterna Zentaris Inc Company Overview 21

5.1.1 Aeterna Zentaris Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Albert Einstein College of Medicine Company Overview 22

5.2.1 Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 AMS Diagnostics LLC Company Overview 24

5.3.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 Axis-Shield Diagnostics Ltd Company Overview 25

5.4.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Carolina Liquid Chemistries Corp Company Overview 26

5.5.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Ceres Nanosciences Inc Company Overview 27

5.6.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Columbia University Company Overview 28

5.7.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 Denka Seiken Co Ltd Company Overview 29

5.8.1 Denka Seiken Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 DIANA Biotechnologies SRO Company Overview 30

5.9.1 DIANA Biotechnologies SRO Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 DiaSorin SpA Company Overview 31

5.10.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 31

5.11 EDP Biotech Corporation Company Overview 34

5.11.1 EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 G Medical Health and Wellness Company Overview 35

5.12.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Guangzhou Wondfo Biotech Co Ltd Company Overview 38

5.13.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 42

5.14.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 42

5.15 Intelligent Bio Solutions Inc Company Overview 43

5.15.1 Intelligent Bio Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.16 Laboratoire HRA Pharma SAS Company Overview 47

5.16.1 Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview 47

5.17 Manchester University NHS Foundation Trust Company Overview 48

5.17.1 Manchester University NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 48

5.18 MyHealthTest Pty Ltd Company Overview 49

5.18.1 MyHealthTest Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 Pearsanta Inc Company Overview 50

5.19.1 Pearsanta Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.20 Philmedi Co Ltd Company Overview 51

5.20.1 Philmedi Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.21 Revvity Inc Company Overview 52

5.21.1 Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.22 Roche Diagnostics Corp Company Overview 53

5.22.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 53

5.23 Roche Diagnostics International Ltd Company Overview 59

5.23.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

5.24 Sendera Discovery Company Overview 66

5.24.1 Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview 66

5.25 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 67

5.25.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

5.26 Siemens Healthcare Diagnostics Inc Company Overview 71

5.26.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.27 Solvd Health Company Overview 88

5.27.1 Solvd Health Pipeline Products & Ongoing Clinical Trials Overview 88

5.28 Thermo Fisher Scientific Inc Company Overview 89

5.28.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.29 Tosoh Bioscience Inc Company Overview 90

5.29.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.30 University of California San Francisco Company Overview 91

5.30.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 91

6 Endocrinology Tests- Recent Developments 92

6.1 Jul 09, 2024: Siemens Healthineers appoints Kalavathi GV as Executive Director and Head of … 92

6.2 Jun 12, 2024: Integrated Diagnostics Holdings Notice of Extraordinary General Meeting 92

6.3 May 30, 2024: Integrated Diagnostics Holdings : First Quarter Results 92

6.4 May 14, 2024: Eckert & Ziegler with Significant Increase in Sales (+17%) and Adjusted EBIT (+41%) in Q1. Forecast 2024 Confirmed 95

6.5 May 14, 2024: NIH-Funded Study Shows BDI’s Bone Density Test Using Existing CT Images Predicts Fractures 96

6.6 May 13, 2024: Novo Nordisk Plans Bond Sale to Fund Expansion 97

6.7 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter 97

6.8 May 02, 2024: Novo Nordisk’s Sales Increased by 22% in Danish kroner and by 24% at Constant Exchange Rates to DKK

65.3 billion in the First Three Months of 2024 98

6.9 Apr 22, 2024: Shenzhen New Industries Biomedical Engineering Receives FDA 510(k) Clearance for MAGLUMI 25-OH Vitamin D Assay 99

6.10 Apr 04, 2024: Roche Diagnostics Receives Additional 510(K) Clearance for Elecsys PTH Assay 99

6.11 Mar 20, 2024: Abingdon Health : Launch of OEM self-tests in Boots 99

6.12 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics 100

6.13 Mar 13, 2024: Research Shows a Blood Test Developed by MFT Could Benefit Thousands of Women Eligible for Preventative Breast Cancer Drug 100

6.14 Mar 11, 2024: Beckman Coulter Receives FDA 510(k) Clearance for Access Intact PTH 102

6.15 Feb 06, 2024: Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President 102

6.16 Jan 18, 2024: IDH appoints Group CFO, VP and Board Member 102

6.17 Dec 05, 2023: Siemens Healthineers Appoints Vivek Kanade as New Head For Its Middle East and Africa Operations 102

6.18 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 102

6.19 Aug 31, 2023: Integrated Diagnostics Holdings Announces Half Year Report 104

6.20 Aug 24, 2023: Immunodiagnostic Systems Holdings Receives 510(k) Clearance for IDS ACTH II Assay 107

7 Appendix 108

7.1 Methodology 108

7.2 About GlobalData 111

7.3 Contact Us 111

7.4 Disclaimer 111

Table

Endocrinology Tests – Pipeline Products by Stage of Development 11

Endocrinology Tests – Pipeline Products by Segment 12

Endocrinology Tests – Pipeline Products by Territory 13

Endocrinology Tests – Pipeline Products by Regulatory Path 14

Endocrinology Tests – Pipeline Products by Estimated Approval Date 15

Endocrinology Tests Companies – Pipeline Products by Stage of Development 16

Endocrinology Tests – Pipeline Products by Stage of Development 18

Aeterna Zentaris Inc Pipeline Products & Ongoing Clinical Trials Overview 21

AEZS-130 Diagnostic Test – Childhood-onset Growth Hormone Deficiency – Product Status 21

AEZS-130 Diagnostic Test – Childhood-onset Growth Hormone Deficiency – Product Description 21

Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 22

Cortisol Assay – Product Status 22

Cortisol Assay – Product Description 22

Progesterone Assay – Product Status 23

Progesterone Assay – Product Description 23

AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Liasys 450 – Vitamin D Assay – Product Status 24

Liasys 450 – Vitamin D Assay – Product Description 24

Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Vitamin D Assay – Product Status 25

Vitamin D Assay – Product Description 25

Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 26

CLC 480 Analyzer – Vitamin D Assay – Product Status 26

CLC 480 Analyzer – Vitamin D Assay – Product Description 26

Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Nanotrap HGH Test – Product Status 27

Nanotrap HGH Test – Product Description 27

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 28

Diagnostic Test – Menopause – Product Status 28

Diagnostic Test – Menopause – Product Description 28

Denka Seiken Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Adiponectin Assay Kit – Product Status 29

Adiponectin Assay Kit – Product Description 29

DIANA Biotechnologies SRO Pipeline Products & Ongoing Clinical Trials Overview 30

DIANA Assay – Insulin-like Growth Factor Receptor – Product Status 30

DIANA Assay – Insulin-like Growth Factor Receptor – Product Description 30

DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 31

LIAISON – High Sclerostin Assay – Product Status 31

LIAISON – High Sclerostin Assay – Product Description 32

LIAISON – Hyperphosphate High Bone Turnover Assay – Product Status 32

LIAISON – Hyperphosphate High Bone Turnover Assay – Product Description 32

LIAISON – Hyperphosphate Low Bone Turnover Assay – Product Status 33

LIAISON – Hyperphosphate Low Bone Turnover Assay – Product Description 33

EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 34

Diagnostic Assay – Early Conception Factor – Product Status 34

Diagnostic Assay – Early Conception Factor – Product Description 34

G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 35

Perimenopause Test – Product Status 35

Perimenopause Test – Product Description 35

Sleep and Stress Test – Product Status 36

Sleep and Stress Test – Product Description 36

Weight Loss Test – Product Status 36

Weight Loss Test – Product Description 37

Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Accre Diagnostic Assay – ACTH – Product Status 38

Accre Diagnostic Assay – ACTH – Product Description 39

Accre Diagnostic Assay – DHEA-S – Product Status 39

Accre Diagnostic Assay – DHEA-S – Product Description 39

Accre Diagnostic Assay – hGH – Product Status 40

Accre Diagnostic Assay – hGH – Product Description 40

Accre Diagnostic Assay – PTH – Product Status 40

Accre Diagnostic Assay – PTH – Product Description 41

Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 42

Immunodiagnostic Assay – Hormones – Product Status 42

Immunodiagnostic Assay – Hormones – Product Description 42

Intelligent Bio Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Diagnostic Test – Adrenal Disorders – Product Status 43

Diagnostic Test – Adrenal Disorders – Product Description 43

Diagnostic Test – Andrology Disorders – Product Status 44

Diagnostic Test – Andrology Disorders – Product Description 44

Diagnostic Test – Gynecological Disorders – Product Status 44

Diagnostic Test – Gynecological Disorders – Product Description 45

Diagnostic Test – Pituitary Disorders – Product Status 45

Diagnostic Test – Pituitary Disorders – Product Description 45

Diagnostic Test – Thyroid Disorders – Product Status 46

Diagnostic Test – Thyroid Disorders – Product Description 46

Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview 47

Indigo – Product Status 47

Indigo – Product Description 47

Manchester University NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 48

Blood Test – Breast Cancer – Product Status 48

Blood Test – Breast Cancer – Product Description 48

MyHealthTest Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Diagnostic Test – Hormones – Product Status 49

Diagnostic Test – Hormones – Product Description 49

Pearsanta Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Mitomic Test – Endocrinology – Product Status 50

Mitomic Test – Endocrinology – Product Description 50

Philmedi Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Cortisol Smart Self Diagnostic Test – Product Status 51

Cortisol Smart Self Diagnostic Test – Product Description 51

Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Accentis – Endocrine Disorders – Product Status 52

Accentis – Endocrine Disorders – Product Description 52

Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 53

Cobas i601 – 24,25OH2 Vit D2 Assay – Product Status 53

Cobas i601 – 24,25OH2 Vit D2 Assay – Product Description 54

Cobas i601 – 24,25OH2 Vit D3 Assay – Product Status 54

Cobas i601 – 24,25OH2 Vit D3 Assay – Product Description 54

Cobas i601 – 25OH Vit D2 Assay – Product Status 55

Cobas i601 – 25OH Vit D2 Assay – Product Description 55

Cobas i601 – 25OH Vit D3 Assay – Product Status 55

Cobas i601 – 25OH Vit D3 Assay – Product Description 56

Cobas i601 – Aldosterone Assay – Product Status 56

Cobas i601 – Aldosterone Assay – Product Description 56

Cobas i601 – Cortisol Assay – Product Status 57

Cobas i601 – Cortisol Assay – Product Description 57

Cobas i601 – Cortisone Assay – Product Status 57

Cobas i601 – Cortisone Assay – Product Description 58

Eftansomatropin Alfa TJ101 Companion Diagnostic Assay – Product Status 58

Eftansomatropin Alfa TJ101 Companion Diagnostic Assay – Product Description 58

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

Cobas 8000 Analyzer Series With c 502 Module – IGF BP3 Assay – Product Status 59

Cobas 8000 Analyzer Series With c 502 Module – IGF BP3 Assay – Product Description 60

Cobas 8000 Analyzer Series With c 502 Module – IGF-1 Assay – Product Status 60

Cobas 8000 Analyzer Series With c 502 Module – IGF-1 Assay – Product Description 60

Cobas 8000 Analyzer Series With c 701 Module – IGF BP3 Assay – Product Status 61

Cobas 8000 Analyzer Series With c 701 Module – IGF BP3 Assay – Product Description 61

Cobas 8000 Analyzer Series With c 701 Module – IGF-1 – Product Status 61

Cobas 8000 Analyzer Series With c 701 Module – IGF-1 – Product Description 62

Cobas 8000 Analyzer Series With c 702 Module – IGF-1 Assay – Product Status 62

Cobas 8000 Analyzer Series With c 702 Module – IGF-1 Assay – Product Description 62

Cobas PIGF Assay – Product Status 63

Cobas PIGF Assay – Product Description 63

Cobas sFlt-1 Assay – Product Status 63

Cobas sFlt-1 Assay – Product Description 64

IGF BP3 Assay – Product Status 64

IGF BP3 Assay – Product Description 64

IGF-1 Assay – Product Status 65

IGF-1 Assay – Product Description 65

Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview 66

Diagnostic Test Kit – Androgen Replacement Therapy – Product Status 66

Diagnostic Test Kit – Androgen Replacement Therapy – Product Description 66

Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

CL-1000i – Calcitonin Test – Product Status 67

CL-1000i – Calcitonin Test – Product Description 67

CL-1000i – Intact PTH Test – Product Status 68

CL-1000i – Intact PTH Test – Product Description 68

CL-1000i – Vitamin D Total Test – Product Status 68

CL-1000i – Vitamin D Total Test – Product Description 69

CL-2000i – hGH Test – Product Status 69

CL-2000i – hGH Test – Product Description 69

CL-2000i – IGF-1 Test – Product Status 70

CL-2000i – IGF-1 Test – Product Description 70

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 71

ADVIA Centaur CP Immunoassay System – Growth Hormone – Product Status 72

ADVIA Centaur CP Immunoassay System – Growth Hormone – Product Description 72

ADVIA Centaur CP Immunoassay System – IGF-I – Product Status 72

ADVIA Centaur CP Immunoassay System – IGF-I – Product Description 73

ADVIA Centaur CP Immunoassay System – IGFBP-3 – Product Status 73

ADVIA Centaur CP Immunoassay System – IGFBP-3 – Product Description 73

ADVIA Centaur CP Immunoassay System – PIGF Assay – Product Status 74

ADVIA Centaur CP Immunoassay System – PIGF Assay – Product Description 74

ADVIA Centaur XP Immunoassay System – ACTH – Product Status 74

ADVIA Centaur XP Immunoassay System – ACTH – Product Description 75

ADVIA Centaur XP Immunoassay System – Growth Hormone – Product Status 75

ADVIA Centaur XP Immunoassay System – Growth Hormone – Product Description 75

ADVIA Centaur XP Immunoassay System – IGFBP-3 – Product Status 76

ADVIA Centaur XP Immunoassay System – IGFBP-3 – Product Description 76

ADVIA Centaur XP Immunoassay System – PIGF Assay – Product Status 76

ADVIA Centaur XP Immunoassay System – PIGF Assay – Product Description 77

ADVIA Centaur XP System – IGF-I Assay – Product Status 77

ADVIA Centaur XP System – IGF-I Assay – Product Description 77

ADVIA Centaur XPT Immunoassay System – ACTH – Product Status 78

ADVIA Centaur XPT Immunoassay System – ACTH – Product Description 78

ADVIA Centaur XPT Immunoassay System – IGFBP-3 – Product Status 78

ADVIA Centaur XPT Immunoassay System – IGFBP-3 – Product Description 79

ADVIA Centaur XPT Immunoassay System – PIGF Assay – Product Status 79

ADVIA Centaur XPT Immunoassay System – PIGF Assay – Product Description 79

ADVIA Centaur XPT Immunoassay System – sFLT-1 Assay – Product Status 80

ADVIA Centaur XPT Immunoassay System – sFLT-1 Assay – Product Description 80

ADVIA Centaur XPT System – Growth Hormone – Product Status 80

ADVIA Centaur XPT System – Growth Hormone – Product Description 81

Atellica IM Analyzer – ACTH Assay – Product Status 81

Atellica IM Analyzer – ACTH Assay – Product Description 81

Atellica IM Analyzer – hGH Assay – Product Status 82

Atellica IM Analyzer – hGH Assay – Product Description 82

Atellica IM Analyzer – IGF-I Assay – Product Status 83

Atellica IM Analyzer – IGF-I Assay – Product Description 83

Atellica IM Analyzer – IGFBP-3 Assay – Product Status 84

Atellica IM Analyzer – IGFBP-3 Assay – Product Description 84

Atellica Solution – IGF-I Assay – Product Status 84

Atellica Solution – IGF-I Assay – Product Description 85

Atellica Solution – IGFBP-3 Assay – Product Status 85

Atellica Solution – IGFBP-3 Assay – Product Description 85

Dimension Vista 1500 Intelligent Lab System – Loci Vitamin D Assay – Product Status 86

Dimension Vista 1500 Intelligent Lab System – Loci Vitamin D Assay – Product Description 86

Dimension Vista Cortisol Assay – Product Status 86

Dimension Vista Cortisol Assay – Product Description 87

Solvd Health Pipeline Products & Ongoing Clinical Trials Overview 88

Endocrinology Diagnostic Screening Test – Product Status 88

Endocrinology Diagnostic Screening Test – Product Description 88

Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Cascadion SM Clinical Analyzer – Endocrinology – Product Status 89

Cascadion SM Clinical Analyzer – Endocrinology – Product Description 89

Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 90

AIA-360 – Vitamin D Test – Product Status 90

AIA-360 – Vitamin D Test – Product Description 90

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 91

Androgen Assay – Product Status 91

Androgen Assay – Product Description 91

Glossary 110

Figures

Endocrinology Tests – Pipeline Products by Stage of Development 11

Endocrinology Tests – Pipeline Products by Segment 12

Endocrinology Tests – Pipeline Products by Territory 13

Endocrinology Tests – Pipeline Products by Regulatory Path 14

Endocrinology Tests – Pipeline Products by Estimated Approval Date 15

Frequently asked questions

Endocrinology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Endocrinology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Endocrinology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Endocrinology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.